Catalyst Wire Dossier Catalyst Wire Dossier

Probiotic therapy to prevent irinotecan-induced diarrhea

· Monsea Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Probiotic therapy to prevent irinotecan-induced diarrhea, covering 2014-01-23 to 2014-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Prevention of Irinotecan Induced Diarrhea by Probiotics [Phase 3]

See pricing